Dultz Georg, Graubard Barry I, Martin Paul, Welker Martin-Walter, Vermehren Johannes, Zeuzem Stefan, McGlynn Katherine A, Welzel Tania M
University Hospital Frankfurt, Frankfurt am Main, Germany.
Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
PLoS One. 2017 Oct 31;12(10):e0186898. doi: 10.1371/journal.pone.0186898. eCollection 2017.
Chronic hepatitis C virus (HCV) infection is a leading cause for orthotopic liver transplantation (OLT) in the U.S. We investigated characteristics of HCV-infected patients registered for OLT, and explored factors associated with mortality. Data were obtained from the United Network for Organ Sharing and Organ Procurement and Transplantation network (UNOS/OPTN) registry. Analyses included 41,157 HCV-mono-infected patients ≥18 years of age listed for cadaveric OLT between February 2002 and June 2014. Characteristics associated with pre- and post-transplant survival and time trends over the study period were determined by logistic and Cox proportional hazard regression analyses and Poisson regressions. Most patients were white (69.1%) and male (70.8%). At waitlist registration, mean age was 54.6 years and mean MELD was 16. HCC was recorded in 26.9% of the records. A total of 51.2% of the patients received an OLT, 21.0% died or were too sick; 15.6% were delisted and 10.4% were still waiting. Factors associated with increased waitlist mortality were older age, female gender, blood type 0, diabetes, no HCC and transplant region (p<0.001). OLT recipient characteristics associated with increased risk for post OLT mortality were female gender, age, diabetes, race (p<0,0001), and allocation MELD (p = 0.005). Donor characteristics associated with waitlist mortality included age, ethnicity (p<0.0001) and diabetes (p<0.03). Waitlist registrations and OLTs for HCC significantly increased from 14.4% to 37.3% and 27.8% to 38.5%, respectively (p<0.0001). Pre- and post-transplant survival depended on a variety of patient-, donor-, and allocation- characteristics of which most remain relevant in the DAA-era. Still, intensified HCV screening strategies and timely and effective treatment of HCV are highly relevant to reduce the burden of HCV-related OLTs in the U.S.
慢性丙型肝炎病毒(HCV)感染是美国原位肝移植(OLT)的主要原因。我们调查了登记接受OLT的HCV感染患者的特征,并探讨了与死亡率相关的因素。数据来自器官共享联合网络和器官获取与移植网络(UNOS/OPTN)登记处。分析纳入了2002年2月至2014年6月期间登记接受尸体OLT的41157例年龄≥18岁的HCV单感染患者。通过逻辑回归和Cox比例风险回归分析以及泊松回归确定与移植前后生存相关的特征以及研究期间的时间趋势。大多数患者为白人(69.1%)和男性(70.8%)。在等待名单登记时,平均年龄为54.6岁,平均终末期肝病模型(MELD)评分为16分。26.9%的记录中记录有肝细胞癌(HCC)。共有51.2%的患者接受了OLT,21.0%的患者死亡或病情过重;15.6%的患者被从等待名单中除名,10.4%的患者仍在等待。与等待名单死亡率增加相关的因素包括年龄较大、女性、血型O、糖尿病、无HCC以及移植区域(p<0.001)。与OLT后死亡率风险增加相关的OLT受者特征包括女性、年龄、糖尿病、种族(p<0.0001)以及分配的MELD评分(p = 0.005)。与等待名单死亡率相关的供者特征包括年龄、种族(p<0.0001)和糖尿病(p<0.03)。HCC患者的等待名单登记和OLT分别从14.4%显著增加至37.3%和从27.8%增加至38.5%(p<0.0001)。移植前后的生存取决于多种患者、供者和分配特征,其中大多数在直接抗病毒药物(DAA)时代仍然相关。尽管如此,强化HCV筛查策略以及及时有效地治疗HCV对于减轻美国HCV相关OLT的负担高度相关。